Literature DB >> 8429226

Elimination of extracellular bacteria by antibiotics in quantitative assays of bacterial ingestion and killing by phagocytes.

S N Tabrizi1, R M Robins-Browne.   

Abstract

In vitro assays to quantify the bactericidal capacity of phagocytes require the removal of extracellular bacteria from the reaction mixture before intracellular bacteria are released from the phagocytic cells and counted. This may be achieved by using an antibiotic, such as gentamicin, which has a rapid bactericidal action coupled with limited ability to cross cytoplasmic membranes. In this study, we investigated the susceptibility of Escherichia coli and Yersinia enterocolitica to killing by mouse peritoneal macrophages. Extracellular bacteria in the reaction mixture were eliminated with gentamicin, whereafter the antibiotic was enzymatically inactivated using gentamicin acetyl transferase (GAT). The method has few washing stages, thus reducing the likelihood of inadvertent removal of macrophages or bacteria from the reaction mixture. The assay disclosed clear differences in the ability of E. coli and Y. enterocolitica to survive phagocytosis by macrophages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429226     DOI: 10.1016/0022-1759(93)90215-s

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Phagocytosis and killing of bacteria by professional phagocytes and dendritic cells.

Authors:  Markus Nagl; Laco Kacani; Brigitte Müllauer; Eva-Maria Lemberger; Heribert Stoiber; Georg M Sprinzl; Harald Schennach; Manfred P Dierich
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae.

Authors:  Hongwei Zhou; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

3.  YopK regulates the Yersinia pestis type III secretion system from within host cells.

Authors:  Rebecca Dewoody; Peter M Merritt; Andrew S Houppert; Melanie M Marketon
Journal:  Mol Microbiol       Date:  2011-01-19       Impact factor: 3.501

4.  In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.

Authors:  Hinda J Ahmed; Catharina Johansson; Liselott A Svensson; Karin Ahlman; Margareta Verdrengh; Teresa Lagergård
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  A flow-cytometric method to evaluate eosinophil-mediated uptake of probiotic Lactobacillus reuteri.

Authors:  Laura S Kraemer; Todd A Brenner; Julia O Krumholz; Helene F Rosenberg
Journal:  J Microbiol Methods       Date:  2017-03-27       Impact factor: 2.363

6.  Dynamics of Increasing IFN-γ Exposure on Murine MH-S Cell-Line Alveolar Macrophage Phagocytosis of Streptococcus pneumoniae.

Authors:  Michael J Mina; Lou Ann S Brown; Keith P Klugman
Journal:  J Interferon Cytokine Res       Date:  2015-02-25       Impact factor: 2.607

7.  The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.

Authors:  Leanne Peiser; Menno P J De Winther; Katherine Makepeace; Michael Hollinshead; Philip Coull; Joyce Plested; Tatsuhiko Kodama; E Richard Moxon; Siamon Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Identification of compounds that decrease numbers of Mycobacteria in human macrophages in the presence of serum amyloid P.

Authors:  Wang Xiang; Nehemiah Cox; Richard H Gomer
Journal:  J Leukoc Biol       Date:  2017-08-02       Impact factor: 4.962

9.  Use of CFSE staining of borreliae in studies on the interaction between borreliae and human neutrophils.

Authors:  Helena Tuominen-Gustafsson; Markus Penttinen; Jukka Hytönen; Matti K Viljanen
Journal:  BMC Microbiol       Date:  2006-10-18       Impact factor: 3.605

10.  Impact of Gentamicin Concentration and Exposure Time on Intracellular Yersinia pestis.

Authors:  Tiva T VanCleave; Amanda R Pulsifer; Michael G Connor; Jonathan M Warawa; Matthew B Lawrenz
Journal:  Front Cell Infect Microbiol       Date:  2017-12-11       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.